Company introduces 'gene writing', to surpass CRISPR's limitations
Wired - 07-Jul-2020New class of gene editors set to remove hurdles of traditional gene therapy
Join the club for FREE to access the whole archive and other member benefits.
Genetic medicine company
Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.
"Our mission is to cure disease by writing in the code of life."
Visit website: https://www.tesseratherapeutics.com/
Details last updated 24-Jul-2020
New class of gene editors set to remove hurdles of traditional gene therapy